Investigational drug · Phase 3
N0728
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms.
Phase 3Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "N0728"
First trial start
2026
Nov 30, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "N0728", any sponsor or status.
Conditions studied
As listed on its trial records.
- Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
Approved drugs for the same conditions: Enlarged prostate (BPH) · Kidney and urology
Largest trials
Live from ClinicalTrials.gov: studies naming "N0728" as an intervention, largest first.
- Efficacy and Safety of Two Fixed-dose Combinations in Men With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. (BENIPRO)Pivotal-lookingNot yet recruiting
Eurofarma Laboratorios S.A.Industry
NCT06546735 · 816 participants (planned) · Start Nov 30, 2026 · Primary completion Apr 30, 2028
Drug: N0728; Vesomni® · For: Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
Sites: São Paulo, Brazil
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.